Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 21, 2007

King Pharmaceuticals’ Facility to Manufacture Syphilis Drug Approved

  • The FDA approved King Pharmaceuticals’ new manufacturing and production facility in Rochester, MI, for its Bicillin® product line.

    According to the company, the recent Sexually Transmitted Diseases Treatment Guidelines issued in 2006 by the CDC recommends penicillin G as the preferred treatment of all stages of syphilis. Bicillin L-A, administered via deep intramuscular injection, has been used for more than 60 years to cure syphilis and prevent sexual transmission, notes Eric J. Bruce, chief technical operations officer, King Pharmaceuticals.”

    To streamline the ease and use of Bicillin L-A, continues Bruce, King is now using the Becton Dickinson Hypack™ Luer-Lok™ syringe system with the Eclipse™ safety-cover needle.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »